Caprion Proteomics Using Applied Biosystems' QTRAP for Assay Development | GenomeWeb

NEW YORK (GenomeWeb News) – Caprion Proteomics said today that it is working with Applied Biosystems to verify and validate protein biomarker candidates for use in clinical settings.

Caprion said it is using the Life Technologies division's QTRAP technology to develop and deploy multiple reaction monitoring (MRM) assays to validate biomarker candidates. The QTRAP technology is used to integrate quantitative and qualitative analysis through the MIDAS workflow and fast MRM assay development and quantitative results, said Caprion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.